Real-World Efficacy and Safety of Universal 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve Patients from a Nationwide HCV Registry in Taiwan Chun-Chi YangChung-Feng HuangMing-Lung Yu Original Research Open access 28 April 2024
Correction to: Virologic Outcomes with Molnupiravir in Nonhospitalized Adult Patients with COVID-19 from the Randomized, Placebo-Controlled MOVe-OUT Trial Julie M. StrizkiJay A. GroblerCarisa De Anda Correction Open access 25 April 2024
Burden of Antimicrobial Resistance in Japan: A Systematic Literature Review and Meta-Analysis Tetsuya MatsumotoAkira YuasaNaohiro Yonemoto Original Research Open access 25 April 2024
Modelling COVID-19 Vaccination in the UK: Impact of the Autumn 2022 and Spring 2023 Booster Campaigns Diana MendesSheeja Machira KrishnanJingyan Yang Original Research Open access 25 April 2024
Systematic Literature Review on the Incidence of Herpes Zoster in Populations at Increased Risk of Disease in the EU/EEA, Switzerland, and the UK Alen MarijamNikki VroomHilde Vroling Original Research Open access 24 April 2024
Prognostic Significance of NLR and PLR in COVID-19: A Multi-Cohort Validation Study Marta ColaneriCamilla GenoveseAndrea Gori Brief Report Open access 21 April 2024
Underlying Neural Mechanisms of Cognitive Improvement in Fronto-striatal Response Inhibition in People Living with HIV Switching Off Efavirenz: A Randomized Controlled BOLD fMRI Trial Patrick G. A. OomenCharlotte S. HakkersStefan du Plessis Original Research Open access 20 April 2024
Fungal Prosthetic Joint Infection: A Case Series and Review of the Literature Victoria StarnesJoan DugganCaitlyn Hollingshead Original Research Open access 13 April 2024
Effect of Regdanvimab on Mortality in Patients Infected with SARS-CoV-2 Delta Variants: A Propensity Score-Matched Cohort Study Soyoon HwangNan Young LeeKi Tae Kwon Original Research Open access 12 April 2024
Ritonavir: 25 Years’ Experience of Concomitant Medication Management. A Narrative Review Romina QuerciaGiovanni Di PerriMarta Boffito Review Open access 12 April 2024
Systematic Review of Heel Puncture-Related Osteomyelitis of the Calcaneus in Newborn Infants Vidmi Taolam MartinIsmail Ahmed DhageyBin Yu Review Open access 08 April 2024
Structured Literature Review to Identify Human Papillomavirus’s Natural History Parameters for Dynamic Population Models of Vaccine Impacts Ibrahim DiakiteBruno MartinsElamin Elbasha Review Open access 08 April 2024
Seroprevalence and Shifting Endemicities of Hepatitis A Virus Infection in Two Different Geographical Areas in the Philippines Josefina C. CarlosVinna Marie T. QuinonesAdriana Guzman-Holst Original Research Open access 05 April 2024
Modelling the Public Health Impact of MenACWY and MenC Adolescent Vaccination Strategies in Germany Sebastian GruhnManuel BatramOliver Damm Original Research Open access 04 April 2024 Pages: 907 - 920
Two-Drug Regimens Dolutegravir/Lamivudine and Dolutegravir/Rilpivirine Are Effective with Few Discontinuations in US Real-World Settings: Results from the TANDEM Study Stefan SchneiderGary BlickAlan Oglesby Original Research Open access 03 April 2024 Pages: 891 - 906
Real-World Effectiveness of Dolutegravir/Lamivudine in People With HIV-1 in Test-and-Treat Settings or With High Baseline Viral Loads: TANDEM Study Subgroup Analyses Paul BensonJennifer KuretskiAlan Oglesby Original Research Open access 03 April 2024 Pages: 875 - 889
Toxic-Induced Encephalopathy Following Chemsex in a Young HIV-Positive Male: A Complex Case of Acute Cognitive Impairment with Anterograde Amnesia and Behavioral Alterations Alexy InciarteLorena de la MoraJosep Mallolas Case Report Open access 03 April 2024 Pages: 647 - 658
Impact of Immunosuppressed Status on Prognosis of Carbapenem-Resistant Organisms Bloodstream Infections Yuan-Yuan LiYan ChenBin Du Original Research Open access 27 March 2024 Pages: 861 - 874
Estimated Incidence of Hospitalizations and Deaths Attributable to Respiratory Syncytial Virus Infections Among Adults in Germany Between 2015 and 2019 Aleksandra Polkowska-KramekElizabeth BegierGernot Rohde Original Research Open access 23 March 2024 Pages: 845 - 860
Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United States Daniel MolnarElizabeth M. LaDesmond Curran Original Research Open access 20 March 2024 Pages: 827 - 844
Estimation of Symptomatic Respiratory Syncytial Virus Infection Incidence in Adults in Multiple Countries: A Time-Series Model-Based Analysis Protocol Robin BruyndonckxAleksandra Polkowska-KramekElizabeth Begier Study Protocol Open access 18 March 2024 Pages: 953 - 963
Best Practices for Identifying Hospitalized Lower Respiratory Tract Infections Using Administrative Data: A Systematic Literature Review of Validation Studies Germaine HanquetChristian TheilackerElizabeth Begier Review Open access 18 March 2024 Pages: 921 - 940
Evaluating the Demand for Nucleic Acid Testing in Different Scenarios of COVID-19 Transmission: A Simulation Study Yu-Yuan WangWei-Wen ZhangMing-xia Jing Original Research Open access 18 March 2024 Pages: 813 - 826
Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-Analysis Using the GRADE Framework Sushma KavikondalaKatrin HaeusslerEkkehard Beck Original Research Open access 18 March 2024 Pages: 779 - 811
Modelling the Public Health Burden of Herpes Zoster and the Impact of Adjuvanted Recombinant Zoster Vaccine in Five Selected Countries in Southeast Asia Ru HanPeter San MartinDésirée A. M. van Oorschot Original Research Open access 17 March 2024 Pages: 761 - 778
Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine Among US Children with Underlying Medical Conditions Mark H. RozenbaumErica ChilsonMark Atwood Original Research Open access 16 March 2024 Pages: 745 - 760
Distinct Lipidomic Profiles between People Living with HIV Treated with E/C/F/TAF or B/F/TAF: An Open-Label Prospective Cohort Study Zhikai WanJunwei SuBiao Zhu Original Research Open access 15 March 2024 Pages: 727 - 744
K-Means Clustering Identifies Diverse Clinical Phenotypes in COVID-19 Patients: Implications for Mortality Risks and Remdesivir Impact Carolina Garcia-VidalChristian Teijón-LumbrerasAlex Soriano Original Research Open access 15 March 2024 Pages: 715 - 726
Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination Timothy E. AlbertsonCaitlin Hansenthe C4591031, C4591007 Clinical Trial Groups Original Research Open access 15 March 2024 Pages: 699 - 714
Effect of Infusion Set Replacement Intervals on Central Line-Associated Bloodstream Infection in the Intensive Care Unit: Study Protocol of the INSPIRATION Study Dandan XuChang HuOn behalf of the INSPIRATION Study group Study Protocol Open access 14 March 2024 Pages: 941 - 951
Household Influenza Transmission and Healthcare Resource Utilization Among Patients Treated with Baloxavir vs Oseltamivir: A United States Outpatient Prospective Survey Jennie H. BestMitra SadeghiMarcus J. Zervos Original Research Open access 14 March 2024 Pages: 685 - 697
Podcast: Need for Quality Evidence for Decision-Making on Seasonal Influenza Vaccines Ann R. FalseyStefania MaggiTor Biering-Sørensen Commentary Open access 14 March 2024 Pages: 659 - 666
Epidemiology of Reportable Bacterial Infectious Diseases in Saudi Arabia Nada K. AlhumaidAreej M. AlajmiEssam A. Tawfik Original Research Open access 10 March 2024 Pages: 667 - 684
Longitudinal Molecular and Serological Evidence of SARS-CoV-2 Infections and Vaccination Status: Community-Based Surveillance Study (CONTACT) Olga Sánchez-SoliñoRyan D. KilpatrickGregory C. Gray Brief Report Open access 10 March 2024 Pages: 633 - 645
Effect of Renal Impairment on Pharmacokinetics and Safety of Ensitrelvir, a SARS-CoV-2 3CL Protease Inhibitor Takayuki KatsubeSafwan KezborRyuji Kubota Original Research Open access 09 March 2024 Pages: 597 - 607
Clinical Characteristics of Uncomplicated Acute Pyelonephritis Caused by Escherichia coli and Klebsiella pneumoniae Miri HyunJi Yeon LeeHyun ah Kim Original Research Open access 09 March 2024 Pages: 581 - 595
Amoebic Liver Abscess: Potential Application of New Diagnostic Techniques for an Old Pathogen Federica PortunatoClaudia BartalucciMatteo Bassetti Case Report Open access 08 March 2024 Pages: 625 - 632
Living During COVID-19 While Immunocompromised: A Patient and Physician Perspective from France Elise FoudratSophie Caillard Commentary Open access 08 March 2024 Pages: 439 - 445
The Impact of the COVID-19 Pandemic on the Incidence of Herpes Zoster: A Narrative Literature Review Raunak ParikhMitra YousefiRobyn Widenmaier Review Open access 05 March 2024 Pages: 447 - 461
4CMenB Vaccination to Prevent Meningococcal B Disease in Vietnam: Expert Review and Opinion Nguyen Phung Nguyen ThePham Quang ThaiNguyen Hoan Le Minh Commentary Open access 02 March 2024 Pages: 423 - 437
Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study Nicholas ReboldSara AlosaimyMichael J. Rybak Original Research Open access 01 March 2024 Pages: 565 - 579
Direct-Acting Antivirals Remain Cost-Effective Treatments for Chronic Hepatitis C in Australia Despite Changes to the Treated Population and the Availability of Retreatment: The Glecaprevir/Pibrentasvir (Maviret®) Example Emma WarrenBelinda J. C. CastlesAitor Arteaga Original Research Open access 01 March 2024 Pages: 549 - 564
Oritavancin Versus Daptomycin for Osteomyelitis Treatment After Surgical Debridement Nicholas W. Van HiseRussell M. PetrakMark Redell Original Research Open access 29 February 2024 Pages: 535 - 547
Safety, Efficacy and Pharmacokinetics of AZD7442 (Tixagevimab/Cilgavimab) for Treatment of Mild-to-Moderate COVID-19: 15-Month Final Analysis of the TACKLE Trial F. D. Richard HobbsHugh MontgomeryMark T. Esser Original Research Open access 25 February 2024 Pages: 521 - 533
Surgical Treatment of Persistent Pseudomonas aeruginosa Bacteraemia After n-Butyl-2-cyanoacrylate for Gastric Bleeding Varices Abiu SempereGabriela ChulloMarta Bodro Case Report Open access 23 February 2024 Pages: 619 - 624
A Population-Based Study on the Incidence, Risk Factors, and Outcome of Salmonella Bloodstream Infections in South Sweden 2012–2022 L. BjörklundY. MattissonO. Ljungquist Original Research Open access 23 February 2024 Pages: 501 - 519
Outcomes of Drug Interactions Between Antiretrovirals and Co-Medications, Including Over-the-Counter Drugs: A Real-World Study Juan AmbrosioniNatalia Anahí DíazJose Molto Brief Report Open access 19 February 2024 Pages: 609 - 617
Cost of Illness Analysis of Invasive Meningococcal Disease Caused by Neisseria Meningitidis Serogroup B in the Netherlands—a Holistic Approach Florian ZeevatJoost J. M. SimonsMaarten J. Postma Original Research Open access 16 February 2024 Pages: 481 - 499
Publisher Correction: Podcast: Influenza-Associated Complications and the Impact of Vaccination on Public Health Stefania MaggiMelissa K. AndrewAnnemarijn de Boer Publisher Correction Open access 16 February 2024 Pages: 421 - 421
A Systematic Literature Review on Risk Factors for and Timing of Clostridioides difficile Infection in the United States Jennifer EeuwijkGui FerreiraMirna Robert-Du Ry van Beest Holle Review Open access 13 February 2024 Pages: 273 - 298